1. Home
  2. HURN vs AMPH Comparison

HURN vs AMPH Comparison

Compare HURN & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huron Consulting Group Inc.

HURN

Huron Consulting Group Inc.

HOLD

Current Price

$181.11

Market Cap

2.8B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.63

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURN
AMPH
Founded
2002
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
1.2B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
HURN
AMPH
Price
$181.11
$26.63
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$190.25
$31.00
AVG Volume (30 Days)
139.0K
396.5K
Earning Date
10-28-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
32.32
N/A
EPS
5.98
2.27
Revenue
$1,618,977,000.00
$723,305,000.00
Revenue This Year
$14.19
$1.35
Revenue Next Year
$9.49
$5.10
P/E Ratio
$30.20
$11.72
Revenue Growth
12.67
N/A
52 Week Low
$118.31
$20.39
52 Week High
$181.50
$40.74

Technical Indicators

Market Signals
Indicator
HURN
AMPH
Relative Strength Index (RSI) 73.99 53.43
Support Level $173.52 $25.16
Resistance Level $181.40 $26.50
Average True Range (ATR) 5.03 0.87
MACD 0.64 -0.04
Stochastic Oscillator 98.37 54.88

Price Performance

Historical Comparison
HURN
AMPH

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: